logo
episode-header-image
Jun 2024
32m 55s

Episode 105: Colorectal Cancer Series, P...

Rouleaux University Medical Center
About this episode

This week, we incorporate medical oncology back into our discussion with our Radiation Oncologist, Dr. Sanford, and our Surgical Oncologist, Dr. Bailey. We discuss how we approach the management of localized rectal cancer. Note that we will be heavily building off our discussions with our specialist. We recommend listening to these episodes if you have not done so already.

Content:

- What information do we need upfront for patients with newly diagnosed rectal cancer?

- How did we get to the current treatment paradigm?

- What is the data for long course vs. short course radiation?

- What is total neoadjuvant therapy?

- What are high risk features in rectal cancer?

- Is surgery always needed?

- Is radiation therapy always needed?

** Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodes

Love what you hear? Tell a friend and leave a review on our podcast streaming platforms!

Twitter: @TheFellowOnCall

Instagram: @TheFellowOnCall

Listen in on: Apple Podcast, Spotify, and Google Podcast

Up next
Sep 17
Episode 139: Follicular Lymphoma Series, Pt 4 - Relapsed/Refractory Management (Cellular therapy options)
This week, we continue talking about relapsed/refractory follicular lymphoma, this time focusing on cellular therapy options, namely bispecific agents and CAR T therapy. If you have not done so, we highly recommend listening to part 3 of our follicular lymphoma series. You may al ... Show More
36m 11s
Sep 10
Episode 138: Follicular Lymphoma Series, Pt 3 - Relapsed/Refractory Management (non-cellular therapy options)
This week, we shift our focus to talking about relapsed/refractory follicular lymphoma. In this episode, we will specifically discuss treatment options other than cellular therapy, which will be an upcoming episode. If you have not done so, we highly recommend listening to part 1 ... Show More
29m 51s
Jun 2025
Episode 137: Follicular Lymphoma Series, Pt 2. - Front-line Management
This week, we continue our conversation on follicular lymphoma, this time focusing on front line therapy. We discuss how we approach localized and diffuse disease and the data behind why we do what we do. Episode contents:- What is the front-line approach to management for locali ... Show More
30m 11s
Recommended Episodes
Sep 4
Colorectal Cancer
Ninja Nerds!In this episode of the Ninja Nerd Podcast, Zach and Rob discuss Colorectal Cancer. This comprehensive discussion focuses on the clinical presentation, pathogenesis, and management of one of the most common malignancies encountered in clinical practice.We start by brea ... Show More
37m 25s
Dec 2024
Non-Muscle Invasive Bladder Cancer Basics with Dr. Kyle Richards
Our guest is Dr. Kyle Richards, a urologic oncologist and Associate Professor in the Department of Urology at the University of Wisconsin. He talks with us about the basics around non-muscle invasive bladder cancer. Learn about common symptoms, diagnosis and treatment options to ... Show More
12m 52s
Mar 2025
Lymphoma
Ninja Nerds,Welcome to the Ninja Nerd Podcast with Zach and Rob! In this episode, we dive deep into Lymphoma, breaking down its pathogenesis, clinical presentation, and the latest advancements in treatment. We explore the key differences between Hodgkin and Non-Hodgkin Lymphoma, ... Show More
34m 14s
Dec 2024
141. Back to Basics - The role of endocrine therapy in Breast Cancer
Before immunotherapy, targeted chemotherapy (ADCs) and precision oncology, there was endocrine therapy, the forefather (or mother) of effective treatment to reduce breast cancer recurrence as well as delay disease progression. This episode dives into a past of phenomenal improvem ... Show More
24m 4s
Sep 24
Episode 65. Circulating Tumor DNA in DLBCL with Dr. Ash Alizadeh and Dr. David Russler-Germain
In this episode of Blood Cancer Talks, hosts Eddie, Ashwin, and Raj welcome two distinguished experts to explore the cutting-edge field of circulating tumor DNA (ctDNA) in B-cell lymphomas. Dr. David Russler-Germain, a lymphoma clinician from Siteman Cancer Centre at Washington U ... Show More
53m 8s
Feb 2025
#325 - What Your Doctor Won’t Tell You About Cancer, Hormones & Healing with Dr Leigh Erin Connealy
I’ve been trying to get Dr. Leigh Erin Connealy on the podcast since last year—and after moving countries twice (and totally butchering her name 🤣 as us Aussies do), we finally made it happen.  It was worth the wait!Dr. Connealy is an absolute powerhouse when it comes to treatin ... Show More
1h 8m
Nov 2021
Ep. 35 Thyroid Nodules with Dr. David Goldenberg
Dr. David Goldenberg talks with us about the management of thyroid nodules, including workup, imaging and patient counseling. --- CHECK OUT OUR SPONSOR Karl Storz TELE PACK+ https://www.karlstorz.com/us/en/telepack.htm --- EARN CME Reflect on how this Podcast applies to your day- ... Show More
44m 2s
Mar 2024
Ep. 422 Pathology 101: Solid Advice for Percutaneous Biopsies with Dr. Andrew Sholl
In this episode of the BackTable Podcast, host Dr. Chris Beck interviews guest Dr. Andrew Sholl, who demystifies the ins and outs of percutaneous biopsies and their impact on diagnoses. Dr. Scholl is a pathologist at LCMC Health in New Orleans, Louisiana. Dr. Sholl emphasizes the ... Show More
55m 5s
Oct 2
Clinical Challenges in Surgical Oncology: Pheochromocytomas
Join the Behind the Knife Surgical Oncology Team as we discuss the nuances in the work up and management of patients with pheochromocytomas. Hosts: Timothy Vreeland, MD, FACS (@vreelant) is an Assistant Professor of Surgery at the Uniformed Services University of the Health Scien ... Show More
28m 30s
Sep 3
The Dr. Ardis Show | True or False: Levothyroxine Increases Risk of Developing Cancers? | Episode 08.27.2025
In this week’s episode of The Dr. Ardis Show, Dr. Ardis sounds the alarm on one of the most widely prescribed thyroid medications in America - levothyroxine. Used by over 22 million Americans to treat hypothyroidism, new research suggests this FDA-approved drug may increase the r ... Show More
40m 50s